7.08 – Kinase Inhibitors for Cancer

作者: A.A. Mortlock , A.J. Barker

DOI: 10.1016/B0-08-045044-X/00209-1

关键词: Signal transductionKinaseTreatment optionsNeuroscienceTumor cellsBiologyDiseaseKinase signalingBioinformatics

摘要: In the 15 years since last edition of Comprehensive Medicinal Chemistry, our understanding signal transduction processes mediated by kinase enzyme cascades, in both health and disease, has increased substantially. The number publications area resources devoted to research on kinases have also grown, reflect importance this target class modern approaches treating cancer. It is clear that perturbation normal systems plays a key role development progression tumors, restoring signaling through appropriate inhibition offers an attractive treatment option for wide variety human tumors. Since cells tumor often appear respond differently inhibition, targets cancer may help avoid or reduce many common side effects associated with conventional cytotoxic therapies while providing effective therapy. This chapter attempts cover progress made identifying small-molecule inhibitors all major presently seen as important text includes brief description disease its characteristics, followed relevance involved further organized according type being discussed, groups related are described within smaller sections. Each section discusses links between cancer, goes describe been developing kinases, refers structural mechanistic information, if it available, how helps properties inhibitors. highlights compounds progressed clinical studies implications any feedback be before final view potential future opportunities issues area. backed up comprehensive up-to-date list supporting references individual provide access review articles covering

参考文章(433)
Norman P, OSI-774 OSI Pharmaceuticals. Current opinion in investigational drugs. ,vol. 2, pp. 298- 304 ,(2001)
Nina Jones, Daniel J Dumont, Tek/Tie2 signaling: new and old partners. Cancer and Metastasis Reviews. ,vol. 19, pp. 13- 17 ,(2000) , 10.1023/A:1026555121511
Charles J. Dimitroff, Wayne Klohs, Amarnath Sharma, Paula Pera, Denise Driscoll, Jean Veith, Randall Steinkampf, Mel Schroeder, Sylvester Klutchko, Adam Sumlin, Barbara Henderson, Thomas J. Dougherty, Ralph J. Bernacki, Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Investigational New Drugs. ,vol. 17, pp. 121- 135 ,(1999) , 10.1023/A:1006367032156
L Détivaud, C Doerig, L Meijer, N Gray, ATP-site directed inhibitors of cyclin-dependent kinases. Current Medicinal Chemistry. ,vol. 6, pp. 859- 875 ,(1999)
Stewart D. Lyman, Sten Eirik W. Jacobsen, c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood. ,vol. 91, pp. 1101- 1134 ,(1998) , 10.1182/BLOOD.V91.4.1101
Joan Albanell, Jordi Codony, Ana Rovira, Begoña Mellado, Pere Gascón, Mechanism of Action of Anti-Her2 Monoclonal Antibodies: Scientific Update on Trastuzumab and 2c4 Advances in Experimental Medicine and Biology. ,vol. 532, pp. 253- 268 ,(2003) , 10.1007/978-1-4615-0081-0_21
ANNIE ZHAO, SEOK H. LEE, MARINA MOIENA, ROSALIND G. JENKINS, DENIS R. PATRICK, HANS E. HUBER, MICHAEL A. GOETZ, OTTO D. HENSENS, DEBORAH L. ZINK, DOLORES VILELLA, ANNE W. DOMBROWSKI, RUSSELL B. LINGHAM, LEEYUAN HUANG, Resorcylic Acid Lactones: Naturally Occurring Potent and Selective Inhibitors of MEK The Journal of Antibiotics. ,vol. 52, pp. 1086- 1094 ,(1999) , 10.7164/ANTIBIOTICS.52.1086
Peter Campochiaro, Stephan Bodis, Doriano Fabbro, Terence O'Reilly, Martin Pruschy, Jeanette Wood, Stephan Ruetz, Thomas Meyer, Katalin Csermak, Anthony Man, PKC412--a protein kinase inhibitor with a broad therapeutic potential. Anti-cancer Drug Design. ,vol. 15, pp. 17- 28 ,(2000)
Randy D. Gascoyne, Patricia Aoun, Daniel Wu, Mukesh Chhanabhai, Brian F. Skinnider, Timothy C. Greiner, Stephan W. Morris, Joseph M. Connors, Julie M. Vose, David S. Viswanatha, Andrew Coldman, Dennis D. Weisenburger, Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma Blood. ,vol. 93, pp. 3913- 3921 ,(1999) , 10.1182/BLOOD.V93.11.3913.411K22_3913_3921
Patrick C Ma, Gautam Maulik, James Christensen, Ravi Salgia, c-Met: Structure, functions and potential for therapeutic inhibition Cancer and Metastasis Reviews. ,vol. 22, pp. 309- 325 ,(2003) , 10.1023/A:1023768811842